Preparation of Phytochlorin E6 (for use in AptocineTM)
D.K. Roper
To Frontier Scienfic, Inc. Aug 2006
Ad5Flgag Phase I Clinical Purification Process Development Summary
D.K. Roper
Merck Research Laboratories Bioprocess R&D, 3 Dec 1999
Campaign Report for New Pneumovax® 8+15 Clinical Formulation Process
J. Taylor, A. Johnson, D.K. Roper
Merck Research Laboratories Bioprocess R&D, 31 Aug 1998
Demonstration Purification Report for 1996 Improved Process for Outer Membrane Protein Complex from Neisseria meningitidis
D.K. Roper, C. Trimor
Merck Research Laboratories Bioprocess R&D, 15 July 1997
Basis of Design Document and Process Skid Package Specification for Pilot Pneumovax Tee-Mix Skid
D.K. Roper
Merck Research Laboratories Bioprocess R&D, 10 March 1997
Basis of Design Document for New Pneumovax® Isolation and Purification Process
R. Lander, M. Gayton, D.K. Roper, A.L. Lee.
Merck Research Laboratories Bioprocess R&D, 10 October 1995
Protein Capture in a Fluidized Bed: Ion Exchange Capture of Acidic Fibroblast Growth Factor from Eschericia coli lysate in a Fluidized Bed of SP Spherodex LS
D.K. Roper
Merck Research Laboratories Bioprocess R&D, 21 August 1991.
